SEHK:2552Pharmaceuticals
Hua Medicine (Shanghai) (SEHK:2552) Stock Faces Profit Squeeze Despite Revenue Traction
Hua Medicine (Shanghai) stock closed at HK$2.60 on Friday, roughly flat over the past month but still down about 20% over three months. The market reaction looks cautious. The headline from these H1 2026 numbers is a clear margin and profit squeeze. Revenue reached CNY 378.9m, yet the company still reported a net loss of CNY 30.2m and a trailing twelve month loss of CNY 107.8m.
For a commercial stage biotech built around dorzagliatin, that gap between a growing top line and continuing losses...